Chrysotile biopersistence: The misuse of biased studies

International Journal of Occupational and Environmental Health

Volumn 15, Issue 1, 2009, Pages 102-106

  Pezerat, Henri ^a  

^a CNRS   (France)

Author keywords

Asbestos; Asbestos Institute; Asbestos related cancer; Biopersistence; Chrysotile; Chrysotile Institute

Indexed keywords

CHRYSOTILE;

ANIMAL; ARTICLE; BIOAVAILABILITY; CHEMICAL INDUSTRY; CHEMISTRY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; HUMAN; INTERPERSONAL COMMUNICATION; LUNG; LUNG TUMOR; MESOTHELIOMA; METABOLISM; OCCUPATIONAL EXPOSURE; STANDARD;

ANIMALS; ASBESTOS, SERPENTINE; BIAS (EPIDEMIOLOGY); BIOLOGICAL AVAILABILITY; CHEMICAL INDUSTRY; COMMUNICATION; ENVIRONMENTAL EXPOSURE; HUMANS; LUNG; LUNG NEOPLASMS; MESOTHELIOMA; OCCUPATIONAL EXPOSURE;

EID: 65249143948     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2009.15.1.102     Document Type: Note

References (55)

1. IARC. Asbestos: Monograph on the Evaluation of Carcinogenic Risk to Man. Lyon, France: International Agency for Research on Cancer. 1988.
2. ATSDR. Toxicological profile for asbestos. U.S. Public Health Service. U.S. Department of Health & Human Services. Atlanta. Agency for Toxic Substances and Disease Registry. 2001.
3. NTP. Report on Carcinogens, Eleventh Edition. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. 2005.
4. WHO. Environmental Health Criteria 203: Chrysotile Asbestos. Geneva. World Health Organization. 1998.
5. Henderson DW, Rödelsperger K, Woitowitz HJ, Leigh J. After Helsinki: A multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology. 2004;36(6):517-50.
6. Hein MJ, Stayner LT, Lehman E, Dement JM. Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. Occup Environ Med. 2007;64(9):616-25.
7. Smith AH, Wright CC. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med.1996;30(3):252-66.
8. Stayner LT, Dankovic DA, Lemen RA. Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health. 1996;86(2):179-86.
9. Yano E, Wang ZM, Wang XR, et al. Cancer mortality among workers exposed to amphibole-free chrysotile asbestos. Am J Epidemiol. 2001;154(6):538-43.
10. Lemen RA. Chrysotile asbestos as a cause of mesothelioma: application of the Hill causation model. Int J Occup Environ Health. 2004;10(2):233-9.
11. Egilman D, Fehnel C, Bohme SR. Exposing the "myth" of ABC, "anything but chrysotile": A critique of the Canadian asbestos mining industry and McGill University chrysotile studies. Am J Ind Med 2003; 44(5):540-557.
12. Mesothelioma News: Russia, world's largest producer of asbestos, protests asbestos ban proposed by international forum. Available from: http://www.mesotheliomanews.com/2007/09/17/russia-worlds-largest-producer-of- asbestos-protestsasbestos-ban-proposed-by-international-forum/.
13. Asbestos Institute: Conclusive Results from a Study by International Scientists Quebec Chrysotile Proven to be Far Less Hazardous. Canadian Corporate News, September, 2003. Available from: http://findarticles.com/p/articles/mi- hb5559/is-200309/ai-n23426424?tag=artBody;col1
14. Egilman D, Roberts M. RE: controlled use of asbestos. Int J Occup Environ Health. Letter. 2004;10(1):99-103..
15. WHO. Elimination of Asbestos-related Diseases. September, 2006. Available from: http://whqlibdoc.who.int/hq/2006/WHO-SDE-OEH-06.03-eng.pdf
16. Chrysotile Institute. A Review of the WHO's Document on the Adverse Health Effects of Exposure to Asbestos and WHO's Recommendations on the Prevention of Asbestos-related Diseases. September, 2008. Available from: http://www.chrysotile.com/en/news/news.aspx/?id=45&lang=en
17. Corbeil réitère l'engagement du gouvernement du Québec à soutenir l'industrie du chrysotile (Minister Corbeil reiterates the government's commitment to sustaining the chrysotile industry). February 25, 2005. Available from: http://www.mrn.gouv.qc.ca/presse/communique- detail.jsp?id=4085.
18. Bernstein DM, Mast R, Anderson R, et al. An experimental approach to the evaluation of the biopersistence of respirable synthetic fibers and minerals. Environ Health Perspect. 1994;102 Suppl 5:15-18.
19. Bernstein DM, Chevalier J, Smith P. Comparison of Calidria chrysotile asbestos to pure tremolite : inhalation biopersistence and histopathology following short-term exposure. Inhal Toxicol. 2003;15(14):1387-419.
20. Bernstein DM, Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation. Inhal Toxicol. 2003;15(13):1247-1274.
21. Bernstein DM, Rogers R, Smith P. The biopersistence of Brazilian chrysotile asbestos following inhalation. Inhal Toxicol. 2004;16(9):745-761.
22. Bernstein DM, Chevalier J, Smith P. Comparison of Calidria chrysotile asbestos to pure tremolite: Final results of inhalation biopersistence and hispathology examination following short-term exposure. Inhal Toxicol. 2005;17(9):427-449.
23. Bernstein DM, Rogers R, Smith P. The biopersistence of Canadian chrysotile asbestos following inhalation: Final results through 1 year after cessation of exposure. Inhal Toxicol. 2005;17(1):1-14.
24. Bernstein DM, Rogers R, Smith P, Chevalier J. The toxicological response of Brazilian chrysotile asbestos: A multidose subchronic 90-day inhalation toxicology study with 92 day recovery to assess cellular and pathological response. Inhal Toxicol. 2006;18(3-6):313-332.
25. WHO Workshop on Mechanisms of Fibre Carcinogenesis and Assessment of Chrysotile Asbestos Substitutes. Lyon, France. November 8-12, 2005. Available from: http://www.who.int/ipcs/publications/new-issues/summary-report.pdf
26. Hughes JM, Weill H, Hammad YY. Mortality of workers employed in two asbestos cement manufacturing plants. Br J Ind Med. 1987 Mar;44(3):161-74.
27. Zalma R, Bonneau L, Guignard J, et al. Formation of oxy-radicals by oxygen reduction arising from the surface activity of asbestos. Can J Chem. 1987;65:2338-2341.
28. Bonneau L, Suquet H, Malard C, Pezerat H. Studies of surface properties of asbestos. I. Active sites on surface of chrysotile and amphiboles. Environ Res. 1986;41:251-267.
29. Fournier J, Guignard J, Nejjari A, et al. The role of iron in the redox surface activity of fibers. Relation to carcinogenicity. In, Mechanisms in Fibre Carcinogenesis. Plenum Press; 1991, p. 407-414.
30. Elias Z, Poirot O, Schneider O, et al. Cytotoxic and transforming effects of some iron-containing minerals in Syrian hamster embryo cells. Cancer detection and prevention. 1995;19(5):405-414
31. Berger M, de Hazen, Nejjari A, Fournier J, et al. Radical oxidation reactions of the purine moiety of 2′-deoxyribonucleosides and DNA by iron-containing minerals. Carcinogenesis. 1993;14(1):41-46.
32. Pott F, Ziem U, Reiffer JF, et al. Carcinogenicity studies on fibers, metal compounds and some others dusts in rats. Exp. Path. 1987; 33(3):129-152.
33. Bertrand R, Pezerat H. Fibrous glass: carcinogenicity and dimensional characteristics. In, Biological Effects of Mineral Fibres, Vol. 2, IARC Scientific Publication No. 30; 1980, p. 901-911.
34. Bonneau L, Malard C, Pezerat H. Studies on surface properties of asbestos. II. Role of dimensional characteristics and surface properties of mineral fibers in the induction of pleural tumors. Environ Res. 1986 ;41 : 268-275
35. Tomatis L, Cantoni S, Carnevale F, et al. The role of asbestos fiber dimensions in the prevention of mesothelioma. Int J Occup Environ Health. 2007;13(1):64-9.
36. Paoletti L, Falchi M, Batisti D, et al. Characterization of asbestos fibers in pleural tissue from 21 cases of mesothelioma. Med Lav.1993;84:373-8.
37. Boutin C, Dumortier P, Rey F, et al. Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic studies. Am J Respir Crit Care. 1996;153:444-9.
38. Suzuki Y, Yuen SR. Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann NY Acad Sci. 2002;982:160-76.
39. Suzuki Y, Yuen SR . Asbestos tissue burden study of human malignant mesothelioma. Ind Health. 2001;39:150-160.
40. Suzuki Y, Yuen SR, Ashley R. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: pathological evidence. Int J Hyg Environ Health. 2005;208:201-10.
41. Dodson RF, Williams MG, Corn CJ, et al. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis. 1990;142:843-7.
42. Bernstein DM. Synthetic vitreous fibers: a review toxicology, epidemiology and regulations. Crit Rev Toxicol. 2007;37(10):839-86. Review.
43. Zalma R, Guignard J, Pezerat H, Jaurand MC. Production of radicals arising from surface activity of fibrous minerals. In, Effects of Mineral Dusts on Cells. Springer Verlag; 1989. p. 257-264.
44. Suquet H. Effects of dry grinding and leaching on the crystal structure of chrysotile. Clays and Clay Minerals. 1989;5:439-445.
45. Kimizuka G, Wang NS, Hayashi Y. Physical and microchemical alterations of chrysotile and amosite asbestos in the hamster lung. J Toxicol Environ Health. 1987; 21: 261-264.
46. Roggli VL, Brody A R. Changes in number and dimensions of chrysotile asbestos fibers in lungs of rats following short-term exposure. Exp Lung Res. 1984;7:133-147.
47. Roggli VL, George MH, Brody AR. Clearance and dimensional changes of crocidolite asbestos fibers isolated from lungs of rats following short-term exposure. Environ Res. 1987;42: 94-105.
48. Coin PG, Roggli VL, Brody AR. Deposition, clearance and translocation of chrysotile asbestos from peripheral and central regions of the rat lung. Environ Res.1992;58:97-116.
49. Coin PG, Roggli VL, Brody AR. Persistence of long, thin chrysotile asbestos fibers in the lungs of rats. Environ Health Perspect. 1994;102,Sup5:197-199.
50. Gardner MJ, Saracci R. Effects on health of non-occupational exposure to airborne. mineral fibers. In Mignon J, Peto J, Saracci R, ed. Non Occupational Exposure to Mineral Fibers. IARC Scientific Publication No. 90, Lyon, France: IARC, 1989:375-97.
51. De Vos Irvine H, Lamont DW, Hole DJ, et al. Asbestos and lung cancer in Glasgow and the west of Scotland. Br J Med. 1993;306:1503-6.
52. Hillerdal G. Mesothelioma cases associated with non-occupational and low dose exposures. Occup Environ Med. 1999;56:505-13.
53. Sebastien P, Janson X, Gaudichet A, et al. Asbestos retention in human respiratory tissues: Comparative measurements in lung parenchyma and in parietal pleura. In: Wagner J ed. Biological Effects of Mineral Fibres. Lyon, France; International Agency for Research on Cancer, 1980, pp 237-246, (IARC Scientific Publications No. 30).
54. Dodson RF, Williams MG, Corn CJ, et al. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis. 1990;142:843-7
55. Kohyama N, Suzuki Y. Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues in North American insulation workers. Ann N Y Acad Sci. 1991;643:27-52.